WithdrawnNot Applicable

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Stopped: Company focus shifted

United States0Started 2020-03-02

Plain-language summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding Alzheimer's disease.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study
✓. Male or female patients age 18 and older
✓. Diagnosis of Alzheimer's disease or dementia by a physician
✓. Mini Mental Status Exam score less than 26

Exclusion criteria

✕. Refusal to sign informed consent form
✕. Treatment with antibiotics within 2 weeks prior to screening
✕. Treatment with probiotics within 2 weeks prior to screening
✕. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
✕. Postoperative stoma, ostomy, or ileoanal pouch
✕. Participation in any experimental drug protocol within the past 12 weeks
✕. Treatment with total parenteral nutrition
✕. Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial

What they're measuring

Correlation of Microbiome to Alzheimer's Disease via Relative Abundance Found in Microbiome Sequencing

Timeframe: 1 year

Trial details

NCT IDNCT04100889

SponsorProgenaBiome

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-03

View on ClinicalTrials.gov More Alzheimer Disease trials